March 2, 2021
Ono Pharmaceutical said on March 1 that it has concluded a non-exclusive license agreement with PeptiDream to work on drug discovery by drawing on the biotech’s proprietary peptide discovery platform system (PDPS). Under the deal, Ono will pay undisclosed sums...read more